These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 19769558)

  • 41. Cognitive behavioural therapy (CBT) compared with blood glucose awareness training (BGAT) in poorly controlled Type 1 diabetic patients: long-term effects on HbA moderated by depression. A randomized controlled trial.
    Snoek FJ; van der Ven NC; Twisk JW; Hogenelst MH; Tromp-Wever AM; van der Ploeg HM; Heine RJ
    Diabet Med; 2008 Nov; 25(11):1337-42. PubMed ID: 19046225
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Tolerability and efficacy of exenatide and titrated insulin glargine in adult patients with type 2 diabetes previously uncontrolled with metformin or a sulfonylurea: a multinational, randomized, open-label, two-period, crossover noninferiority trial.
    Barnett AH; Burger J; Johns D; Brodows R; Kendall DM; Roberts A; Trautmann ME
    Clin Ther; 2007 Nov; 29(11):2333-48. PubMed ID: 18158075
    [TBL] [Abstract][Full Text] [Related]  

  • 43. A change of units for HbA(1c).
    Drug Ther Bull; 2010 Feb; 48(2):23-4. PubMed ID: 20147433
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Challenges of optimizing glycaemic control in children with Type 1 diabetes: a qualitative study of parents' experiences and views.
    Lawton J; Waugh N; Barnard KD; Noyes K; Harden J; Stephen J; McDowell J; Rankin D
    Diabet Med; 2015 Aug; 32(8):1063-70. PubMed ID: 25472898
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Consensus statement on the care of the hyperglycaemic/diabetic patient during and in the immediate follow-up of acute coronary syndrome.
    Vergès B; Avignon A; Bonnet F; Catargi B; Cattan S; Cosson E; Ducrocq G; Elbaz M; Fredenrich A; Gourdy P; Henry P; Lairez O; Leguerrier AM; Monpère C; Moulin P; Vergès-Patois B; Roussel R; Steg G; Valensi P; ;
    Arch Cardiovasc Dis; 2012 Apr; 105(4):239-53. PubMed ID: 22808525
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Optimization of insulin therapy in patients with type 2 diabetes mellitus: beyond basal insulin.
    Blak BT; Smith HT; Hards M; Curtis BH; Ivanyi T
    Diabet Med; 2012 Jul; 29(7):e13-20. PubMed ID: 22268988
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Intensive glucose control and cardiovascular outcomes in type 2 diabetes.
    Macisaac RJ; Jerums G
    Heart Lung Circ; 2011 Oct; 20(10):647-54. PubMed ID: 20807681
    [TBL] [Abstract][Full Text] [Related]  

  • 48. A(1c) control in a primary care setting: self-titrating an insulin analog pre-mix (INITIATEplus trial).
    Oyer DS; Shepherd MD; Coulter FC; Bhargava A; Brett J; Chu PL; Trippe BS;
    Am J Med; 2009 Nov; 122(11):1043-9. PubMed ID: 19854333
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Insulin during pregnancy, labour and delivery.
    de Valk HW; Visser GH
    Best Pract Res Clin Obstet Gynaecol; 2011 Feb; 25(1):65-76. PubMed ID: 21186142
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Efficacy and tolerability of exenatide monotherapy over 24 weeks in antidiabetic drug-naive patients with type 2 diabetes: a randomized, double-blind, placebo-controlled, parallel-group study.
    Moretto TJ; Milton DR; Ridge TD; Macconell LA; Okerson T; Wolka AM; Brodows RG
    Clin Ther; 2008 Aug; 30(8):1448-60. PubMed ID: 18803987
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A randomized, treat-to-target trial comparing insulin lispro protamine suspension and insulin detemir in insulin-naive patients with Type 2 diabetes.
    Fogelfeld L; Dharmalingam M; Robling K; Jones C; Swanson D; Jacober S
    Diabet Med; 2010 Feb; 27(2):181-8. PubMed ID: 20546262
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Relating mean blood glucose and glucose variability to the risk of multiple episodes of hypoglycaemia in type 1 diabetes.
    Kilpatrick ES; Rigby AS; Goode K; Atkin SL
    Diabetologia; 2007 Dec; 50(12):2553-61. PubMed ID: 17882397
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The relationship between glycaemic control and mortality in patients with type 2 diabetes in general practice (ZODIAC-11).
    Landman GW; van Hateren KJ; Kleefstra N; Groenier KH; Gans RO; Bilo HJ
    Br J Gen Pract; 2010 Mar; 60(572):172-5. PubMed ID: 20202363
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Benefits of continuous subcutaneous insulin infusion in children with type 1 diabetes.
    Willi SM; Planton J; Egede L; Schwarz S
    J Pediatr; 2003 Dec; 143(6):796-801. PubMed ID: 14657831
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Initiation of insulin glargine therapy in type 2 diabetes subjects suboptimally controlled on oral antidiabetic agents: results from the AT.LANTUS trial.
    Davies M; Lavalle-González F; Storms F; Gomis R;
    Diabetes Obes Metab; 2008 May; 10(5):387-99. PubMed ID: 18355327
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Review of hemoglobin A(1c) in the management of diabetes.
    Gallagher EJ; Le Roith D; Bloomgarden Z
    J Diabetes; 2009 Mar; 1(1):9-17. PubMed ID: 20923515
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Antidiabetic prescriptions and glycemic control in German patients with type 2 diabetes mellitus: a retrospective database study.
    Yurgin N; Secnik K; Lage MJ
    Clin Ther; 2007 Feb; 29(2):316-25. PubMed ID: 17472823
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Diabetes care, glycemic control, and complications in children with type 1 diabetes from Asia and the Western Pacific Region.
    Craig ME; Jones TW; Silink M; Ping YJ
    J Diabetes Complications; 2007; 21(5):280-7. PubMed ID: 17825751
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Effect of automated bio-behavioral feedback on the control of type 1 diabetes.
    Kovatchev BP; Mendosa P; Anderson S; Hawley JS; Ritterband LM; Gonder-Frederick L
    Diabetes Care; 2011 Feb; 34(2):302-7. PubMed ID: 21216860
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Vildagliptin plus metformin combination therapy provides superior glycaemic control to individual monotherapy in treatment-naive patients with type 2 diabetes mellitus.
    Bosi E; Dotta F; Jia Y; Goodman M
    Diabetes Obes Metab; 2009 May; 11(5):506-15. PubMed ID: 19320662
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.